← Leaderboards
David A Ehrmann
University Of Chicago
$20,892,373
Attributed
$23,438,379
Total exposure
21
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$29,353,943 · 22
By mechanism
U01$14,709,448 · 2
P50$11,831,128 · 6
R01$1,438,649 · 1
M01$1,374,718 · 13
Top collaborators
- Eve Van Cauter10 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Eve Van Cauter$20,092,700
- Xiaoyang Wu$5,862,035
- Elaine M Worcester$4,228,333
- Andrew M Wolfe$3,333,015
- Robert L Rosenfield$3,734,702
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectWomanRisk FactorsObesityBaseGlucosePharmaceutical PreparationsDiabetes MellitusSleepPlacebosCardiovascular DiseasesMetabolicSleep Apnea SyndromesProgramsPolycystic Ovary SyndromePrevalenceInsulinDesignInsulin ResistanceNon-Insulin-Dependent Diabetes MellitusAftercarePreventContinuous Positive Airway PressureInsulin Sensitivity
Grant awards (85)
2/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center$1
U01 · FY2021 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$385,298
U01 · FY2020 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$421,501
U01 · FY2019 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$408,830
U01 · FY2018 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$433,237
U01 · FY2017 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$378,423
U01 · FY2016 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$55,300
U01 · FY2016 · DK · contact PI
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$28,601
U01 · FY2016 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$832,900
U01 · FY2015 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$399,999
U01 · FY2015 · DK · contact PI
DPPOS Follow-up$360,596
U01 · FY2015 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$303,595
U01 · FY2015 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$630,252
U01 · FY2014 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$449,988
U01 · FY2014 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$260,687
U01 · FY2014 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$542,335
U01 · FY2013 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$470,316
U01 · FY2013 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$254,321
U01 · FY2013 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$606,985
U01 · FY2012 · DK · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$551,221
U01 · FY2012 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$498,558
U01 · FY2012 · DK · contact PI
Sex steroids, Sleep, and Metabolic Dysfunction in Women$1,193,834
P50 · FY2011 · HD · contact PI
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment$709,717
U01 · FY2011 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$484,221
U01 · FY2011 · DK · contact PI
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women$348,482
P50 · FY2011 · HD · contact PI
Sleep and Metabolism in Obesity: Impact of Gender$310,876
P50 · FY2011 · HD · contact PI
PCOS, Sleep Apnea, and Metabolic Risk in Women$305,830
P50 · FY2011 · HD · contact PI
Assessment of Adipocyte Function in Women with PCOS$228,646
P50 · FY2011 · HD · contact PI
Sex steroids, Sleep, and Metabolic Dysfunction in Women$1,210,293
P50 · FY2010 · HD · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$462,882
U01 · FY2010 · DK · contact PI
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women$352,290
P50 · FY2010 · HD · contact PI
Sleep and Metabolism in Obesity: Impact of Gender$315,412
P50 · FY2010 · HD · contact PI
PCOS, Sleep Apnea, and Metabolic Risk in Women$311,452
P50 · FY2010 · HD · contact PI
Assessment of Adipocyte Function in Women with PCOS$231,139
P50 · FY2010 · HD · contact PI
Sex steroids, Sleep, and Metabolic Dysfunction in Women$1,191,360
P50 · FY2009 · HD · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$462,882
U01 · FY2009 · DK · contact PI
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women$345,773
P50 · FY2009 · HD · contact PI
Sleep and Metabolism in Obesity: Impact of Gender$310,730
P50 · FY2009 · HD · contact PI
PCOS, Sleep Apnea, and Metabolic Risk in Women$307,997
P50 · FY2009 · HD · contact PI
Assessment of Adipocyte Function in Women with PCOS$226,860
P50 · FY2009 · HD · contact PI
Sex steroids, Sleep, and Metabolic Dysfunction in Women$1,158,227
P50 · FY2008 · HD · contact PI
Post-Diabetes Prevention Program (DPP)$417,416
U01 · FY2008 · DK · contact PI
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women$335,321
P50 · FY2008 · HD · contact PI
Sleep and Metabolism in Obesity: Impact of Gender$301,898
P50 · FY2008 · HD · contact PI
PCOS, Sleep Apnea, and Metabolic Risk in Women$300,992
P50 · FY2008 · HD · contact PI
Assessment of Adipocyte Function in Women with PCOS$220,016
P50 · FY2008 · HD · contact PI
Sex steroids, Sleep, and Metabolic Dysfunction in Women$1,161,850
P50 · FY2007 · HD · contact PI
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women$284,935
P50 · FY2007 · HD · contact PI
PCOS, Sleep Apnea, and Metabolic Risk in Women$258,606
P50 · FY2007 · HD · contact PI
Sleep and Metabolism in Obesity: Impact of Gender$258,511
P50 · FY2007 · HD · contact PI
Post-Diabetes Prevention Program (DPP)$250,923
U01 · FY2007 · DK · contact PI
Assessment of Adipocyte Function in Women with PCOS$188,385
P50 · FY2007 · HD · contact PI
Administrative Core$171,413
P50 · FY2007 · HD · contact PI
SLEEP AND PCOS$76,642
M01 · FY2007 · RR · contact PI
GENETICS OF PCOS$7,579
M01 · FY2007 · RR · contact PI
PIOGLITAZONE & ETHINYL ESTRADIOL/DROSPERINONE IN THE TREATMENT OF PCOS$6,177
M01 · FY2007 · RR · contact PI
Post-Diabetes Prevention Program (DPP)$416,920
U01 · FY2006 · DK · contact PI
Sleep, Metabolic, and Cardiovascular Dysfunction in PCOS$354,860
R01 · FY2006 · HL · contact PI
SLEEP APNEA AND POLYCYSTIC OVARY SYNDROME$336,654
M01 · FY2006 · RR · contact PI
PIOGLITAZONE & ETHINYL ESTRADIOL/DROSPERINONE IN THE TREATMENT OF PCOS$50,498
M01 · FY2006 · RR · contact PI
GENETICS & TREATMENT OF INSULIN SECRETION IN PCOS$11,924
M01 · FY2006 · RR · contact PI
SLEEP APNEA AND POLYCYSTIC OVARY SYNDROME$554,362
M01 · FY2005 · RR
Post-Diabetes Prevention Program (DPP)$398,513
U01 · FY2005 · DK
Sleep, Metabolic, and Cardiovascular Dysfunction in PCOS$361,263
R01 · FY2005 · HL
GENETICS &TREATMENT OF INSULIN SECRETION IN PCOS$42,471
M01 · FY2005 · RR
DIABETES PREVENTION PROGRAM OUTCOMES STUDY$19,374
M01 · FY2005 · RR
Post-Diabetes Prevention Program (DPP)$398,513
U01 · FY2004 · DK
Sleep, Metabolic, and Cardiovascular Dysfunction in PCOS$361,263
R01 · FY2004 · HL
Genetics &Treatment of Insulin Secretion in PCOS$115,918
M01 · FY2004 · RR
DPPOS$114,147
M01 · FY2004 · RR
Sleep Apnea and Polycystic Ovary Syndrome$6,193
M01 · FY2004 · RR
Post-Diabetes Prevention Program (DPP)$489,657
U01 · FY2003 · DK
Sleep, Metabolic, and Cardiovascular Dysfunction in PCOS$361,263
R01 · FY2003 · HL
DIABETES PREVENTION PROGRAM$294,907
U01 · FY2002 · DK
METABOLIC AND GENETIC SCREENING OF FAMILIES WITH DIABETES$0
M01 · FY2002 · RR
ACTIVATIONAL EFFECT OF HORMONES ON EMOTIONAL &COGNITIVE FUNCTIONING$0
M01 · FY2002 · RR
OVARIAN STEROIDOGENESIS AND INSULIN RESISTANCE$0
M01 · FY2002 · RR
DIABETES PREVENTION PROGRAM$833,382
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM$816,571
U01 · FY2000 · DK
ACTIVATIONAL EFFECT OF HORMONES ON EMOTIONAL &COGNITIVE FUNCTIONING$32,779
M01 · FY2000 · RR
METABOLIC AND GENETIC SCREENING OF FAMILIES WITH DIABETES$0
M01 · FY2000 · RR
ACTIVATIONAL EFFECT OF HORMONES ON EMOTIONAL &COGNITIVE FUNCTIONING$0
M01 · FY2000 · RR
OVARIAN STEROIDOGENESIS AND INSULIN RESISTANCE$0
M01 · FY2000 · RR
OVARIAN STEROIDOGENESIS AND INSULIN RESISTANCE$0
M01 · FY2000 · RR
METABOLIC AND GENETIC SCREENING OF FAMILIES WITH DIABETES$0
M01 · FY2000 · RR